Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. (Q53632406)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. |
scientific article |
Statements
Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. (English)
1 reference
Hong-yu Li
1 reference
Yan Wang
1 reference
Charles R Heap
1 reference
Chi-Hsin R King
1 reference
Sreenivasa R Mundla
1 reference
Matthew Voss
1 reference
David K Clawson
1 reference
Lei Yan
1 reference
Robert M Campbell
1 reference
Bryan D Anderson
1 reference
Jill R Wagner
1 reference
Karen Britt
1 reference
Ku X Lu
1 reference
William T McMillen
1 reference
Jonathan M Yingling
1 reference
1 March 2006
1 reference
49
1 reference
2138-2142
1 reference
6
1 reference
Identifiers
1 reference